Qiagen is to expand its personalised healthcare portfolio by developing and commercialising six new molecular tests by 2011 in collaboration with fellow Dutch firm Genome Diagnostics. The next-generation tests will be developed by Genome Diagnostics and will detect the genetic ...
Please Login to read the full article.
